Volume 15, Issue 4 (1-2020)
HSR 2020, 15(4): 280-287 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ahmadi H, Mottaghi T, Khorvash F, Feizi A, Bagherniya M, Askari G. Effect of Zinc Supplementation on Symptoms and C-Reactive Protein among Patients with Migraine: A Double-blind Randomized Placebo-controlled Clinical Trial. HSR 2020; 15 (4) :280-287
URL: http://hsr.mui.ac.ir/article-1-1103-en.html
URL: http://hsr.mui.ac.ir/article-1-1103-en.html
Hedieh Ahmadi 
1, Tayebeh Mottaghi2 , Fariborz Khorvash3 , Awat Feizi4 , Mohammad Bagherniya5 , Gholamreza Askari6
1, Tayebeh Mottaghi2 , Fariborz Khorvash3 , Awat Feizi4 , Mohammad Bagherniya5 , Gholamreza Askari6
1- MSc Student of Nutrition, Food Safety Research Center, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
2- PhD Student of Nutrition, Food Safety Research Center, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
3- Assistant Professor, Neurology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
4- Assistant Professor, Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
5- PhD of Nutrition, Department of Community Nutrition, Food Security Research Center, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
6- Assistant Professor, Department of Community Nutrition, Food Security Research Center, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
2- PhD Student of Nutrition, Food Safety Research Center, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
3- Assistant Professor, Neurology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
4- Assistant Professor, Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
5- PhD of Nutrition, Department of Community Nutrition, Food Security Research Center, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
6- Assistant Professor, Department of Community Nutrition, Food Security Research Center, School of Nutrition and Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract: (1418 Views)
Background: Prevalence of migraine is reported at 14.7% and 14% around the world and Iran, respectively. Zinc deficiency is recognized as one of the nutritional problems worldwide. People with migraines have lower levels of zinc, as compared to healthy individuals. The present study aimed to determine the effect of zinc supplementation on symptoms and C-Reactive Protein as a sensitive marker of inflammation among patients with migraine.
Methods: This double-blinded randomized clinical study was conducted on 80 patients with migraine in Isfahan, Iran, in 2016. Participants were randomly assigned to the intervention and control groups. The patients in the intervention and control groups received one daily dose of 220 mg zinc sulfate (50 mg zinc) and a placebo (starch) for 8 weeks. The symptoms of migraine attacks, including the severity of headache, frequency and duration of headache, headache diary result (HDR), and C-Reactive Protein (CRP) levels were measured for each patient at baseline and at the end of the trial.
Findings: At the commencement of the study, there was no significant difference between the two groups regarding migraine symptoms. In addition, the intervention decreased the severity (P=0.048), frequency (P = 0.026), and headache diary result (HDR) (P=0.02), as compared to the placebo. Nonetheless, the two groups were significantly different regarding the mean duration of headache attacks (P=0.092).
Conclusion: As evidenced by the obtained results, zinc supplementation for 8 weeks may be an effective treatment for migraine symptoms.
Methods: This double-blinded randomized clinical study was conducted on 80 patients with migraine in Isfahan, Iran, in 2016. Participants were randomly assigned to the intervention and control groups. The patients in the intervention and control groups received one daily dose of 220 mg zinc sulfate (50 mg zinc) and a placebo (starch) for 8 weeks. The symptoms of migraine attacks, including the severity of headache, frequency and duration of headache, headache diary result (HDR), and C-Reactive Protein (CRP) levels were measured for each patient at baseline and at the end of the trial.
Findings: At the commencement of the study, there was no significant difference between the two groups regarding migraine symptoms. In addition, the intervention decreased the severity (P=0.048), frequency (P = 0.026), and headache diary result (HDR) (P=0.02), as compared to the placebo. Nonetheless, the two groups were significantly different regarding the mean duration of headache attacks (P=0.092).
Conclusion: As evidenced by the obtained results, zinc supplementation for 8 weeks may be an effective treatment for migraine symptoms.
Type of Study: Research |
Subject:
education health and promotion
Received: 2020/07/16 | Accepted: 2020/01/15 | Published: 2020/01/15
Received: 2020/07/16 | Accepted: 2020/01/15 | Published: 2020/01/15
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
